{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:24:25Z","timestamp":1777623865202,"version":"3.51.4"},"reference-count":35,"publisher":"Japan Atherosclerosis Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2024,12,1]]},"DOI":"10.5551\/jat.64988","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T22:14:34Z","timestamp":1718403274000},"page":"1748-1762","source":"Crossref","is-referenced-by-count":6,"title":["Early, Intensive and Persistent Lipid-Lowering Therapy for Secondary Prevention of Acute Coronary Syndrome"],"prefix":"10.5551","volume":"31","author":[{"given":"Kozo","family":"Okada","sequence":"first","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"},{"name":"YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Haze","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Yokohama City University Medical Center"},{"name":"YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinnosuke","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekuni","family":"Kirigaya","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Hanajima","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Kirigaya","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidefumi","family":"Nakahashi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Gohbara","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Kosuge","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Ebina","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruyasu","family":"Sugano","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Hibi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, V Elkind MS, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation, 2022; 145: e153-e639","DOI":"10.1161\/CIR.0000000000001052"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H, Kobayashi M, Isshiki T, on behalf of the PACIFIC investigators. Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J, 2013; 77: 934-943","DOI":"10.1253\/circj.CJ-13-0174"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. Intensive vs. moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med, 2004; 350: 1495-1504","DOI":"10.1056\/NEJMoa040583"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. J Am Coll Cardiol, 2018; 72: 1141-1156","DOI":"10.1016\/j.jacc.2018.06.046"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Niccoli G, Montone RA, Di Vito L, Gramegna M, Refaat H, Scalone G, Leone AM, Trani C, Burzotta F, Porto I, Aurigemma C, Prati F, Crea F. Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome. Eur Heart J, 2015; 36: 1377-1384","DOI":"10.1093\/eurheartj\/ehv029"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Okada K, Hibi K, Kikuchi S, Kirigaya H, Hanajima Y, Sato R, Nakahashi H, Minamimoto Y, Matsuzawa Y, Maejima N, Iwahashi N, Kosuge M, Ebina T, Tamura K, Kimura K. Culprit Lesion Morphology of Rapidly Progressive and Extensive Anterior-Wall ST-Segment Elevation Myocardial Infarction. Circ Cardiovasc Imaging, 2022; 15: e014497","DOI":"10.1161\/CIRCIMAGING.122.014497"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ahmadi A, Argulian E, Leipsic J, Newby DE, Narula J. From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review. J Am Coll Cardiol, 2019; 74: 1608-1617","DOI":"10.1016\/j.jacc.2019.08.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA, 2006; 295: 1556-1565","DOI":"10.1001\/jama.295.13.jpc60002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. JAMA, 2016; 316: 1289-1297","DOI":"10.1001\/jama.2016.13985"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) White HD. Value of expert opinion in recommending early intensive lipid lowering in patients with ACS. Eur Heart J Acute Cardiovasc Care, 2022; 11: 936-938","DOI":"10.1093\/ehjacc\/zuac136"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, Ferranti Sd, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2019; 139: e1082-e1143","DOI":"10.1161\/CIR.0000000000000624"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, Sakamoto T, Tsujita K, Hagiwara N, Miyazaki S, Ako J, Arai H, Ishii H, Origuchi H, Shimizu W, Takemura H, Tahara Y, Morino Y, Iino K, Itoh T, Iwanaga Y, Uchida K, Endo H, Kongoji K, Sakamoto K, Shiomi H, Shimohama T, Suzuki A, Takahashi J, Takeuchi I, Tanaka A, Tamura T, Nakashima T, Noguchi T, Fukamachi D, Mizuno T, Yamaguchi J, Yodogawa K, Kosuge M, Kohsaka S, Yoshino H, Yasuda S, Shimokawa H, Hirayama A, Akasaka T, Haze K, Ogawa H, Tsutsui H, Yamazaki T, on behalf of the Japanese Circulation Society Joint Working Group. JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome. Circ J, 2019; 83: 1085-1196","DOI":"10.1253\/circj.CJ-19-0133"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J, 2020; 41: 111-188","DOI":"10.15829\/1560-4071-2020-3826"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Oki K, Inagaki N, Okamura S, Kai T, Izawa S, Yamada M, Chiba Y, Tanabe A, Naruse M. Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism. Atherosclerosis, 2021; 324: 84-90","DOI":"10.1016\/j.atherosclerosis.2021.03.033"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Lopes MB, Karaboyas A, Bieber B, Pisoni RL, Walpen S, Fukagawa M, Christensson A, Evenepoel P, Pegoraro M, Robinson BM, Pecoits-Filho R. Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS. Nephrol Dial Transplant, 2020; 35: 1794-1801","DOI":"10.1093\/ndt\/gfaa054"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zhang Z, Reinikainen J, Adeleke KA, Pieterse ME, Groothuis-Oudshoorn CGM. Time-varying covariates and coefficients in Cox regression models. Ann Transl Med, 2018; 6: 121","DOI":"10.21037\/atm.2018.02.12"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Bender A, Groll A, Scheipl F. A generalized additive model approach to time-to-event analysis. Statistical Modelling, 2018; 18: 299-321","DOI":"10.1177\/1471082X17748083"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Scheike TH, Zhang MJ. Flexible competing risks regression modeling and goodness-of-fit. Lifetime Data Anal, 2008; 14: 464-483","DOI":"10.1007\/s10985-008-9094-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gerds TA, Scheike TH, Andersen PK. Absolute risk regression for competing risks: interpretation, link functions, and prediction. Stat Med, 2012; 31: 3921-3930","DOI":"10.1002\/sim.5459"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yeo I, Johnson RA. A new family of power transformations to improve normality or symmetry. Biometrika, 2000; 87: 954-959","DOI":"10.1093\/biomet\/87.4.954"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Nakamura M, Ako J, Arai H, Hirayama A, Nohara A, Murakami Y, Ozaki A, Harada-Shiba M. Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J. J Atheroscler Thromb, 2021; 28: 1307-1322","DOI":"10.5551\/jat.59543"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sachdeva A, Cannon CP, Deedwania PC, LaBresh KA, Smith SC, Dai D, Hernandez A, Fonarow GC. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J, 2009; 157: 111-117 e2","DOI":"10.1016\/j.ahj.2008.08.010"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hulten E, Jackson JL, Douglas K, George S, Villines TC. The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials. Arch Intern Med, 2006; 166: 1814-1821","DOI":"10.1001\/archinte.166.17.1814"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Yanagisawa N, Tamura H, Kojima T, Yokoyama K, Kurata T, Daida H. Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study. Atherosclerosis, 2010; 210: 497-502","DOI":"10.1016\/j.atherosclerosis.2009.12.001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White Harvey D, Zeiher AM. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med, 2018; 379: 2097-2107","DOI":"10.1056\/NEJMoa1801174"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, Ferrari GMD, Ruzyllo W, Lucca PD, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med, 2015; 372: 2387-97","DOI":"10.1056\/NEJMoa1410489"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T, for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA, 2001; 285: 1711-1718","DOI":"10.1001\/jama.285.13.1711"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nicholls SJ, Kataoka Y, Nissen SE, Prati F, Windecker S, Puri R, Hucko T, Aradi D, Herrman JPR, Hermanides RS, Wang B, Wang H, Butters J, Di Giovanni G, Jones S, Pompili G, Psaltis PJ. Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction. JACC Cardiovasc Imaging, 2022; 15: 1308-1321","DOI":"10.1016\/j.jcmg.2022.03.002"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial. J Am Coll Cardiol, 2015; 66: 495-507","DOI":"10.1016\/j.jacc.2015.05.065"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kini AS, Baber U, Kovacic JC , Limaye A, Ali ZA, Sweeny J, Maehara A, Mehran R, Dangas G, Mintz GS, Fuster V, Narula J, Sharma SK, Moreno PR. Changes in plaque lipid content after short-term intensive vs. standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). J Am Coll Cardiol, 2013; 62: 21-29","DOI":"10.1016\/j.jacc.2013.03.058"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Nishiguchi T, Kubo T, Tanimoto , Ino Y, Matsuo Y, Yamano T, Terada K, Emori H, Katayama Y, Taruya A, Ozaki Y, Shiono Y, Shimamura K, Kameyama T, Kitabata H, Yamaguchi T, Tanaka A, Hozumi T, Akasaka T. Effect of Early Pitavastatin Therapy on Coronary Fibrous-Cap Thickness Assessed by Optical Coherence Tomography in Patients With Acute Coronary Syndrome: The ESCORT Study. JACC Cardiovasc Imaging, 2018; 11: 829-838","DOI":"10.1016\/j.jcmg.2017.07.011"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, Daida H. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation, 2004; 110: 1061-1068","DOI":"10.1161\/01.CIR.0000140261.58966.A4"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Omori H, Ota H, Mizukami T , Kawase Y, Tanigaki T, Hirata T, Okubo M, Kawasaki M, Matsuo H. How Do Coronary Lipid-Rich Plaques Change After Cessation of Proprotein Convertase Subtilisin\/Kexin Type 9 Inhibitors? - Serial Assessment Using Near-Infrared Spectroscopy. Circ J, 2021; 85: 1404","DOI":"10.1253\/circj.CJ-21-0211"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Ray KK, Troquay RPT, Visseren FLJ , Leiter LA, Scott Wright R, Vikarunnessa S, Talloczy Z, Zang X, Maheux P, Lesogor A, Landmesser U. Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial. Lancet Diabetes Endocrinol, 2023; 11: 109-119","DOI":"10.1016\/S2213-8587(22)00353-9"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Jansen H, Samani NJ, Schunkert H. Mendelian randomization studies in coronary artery disease. Eur Heart J, 2014; 35: 1917-1924","DOI":"10.1093\/eurheartj\/ehu208"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/12\/31_64988\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T04:10:41Z","timestamp":1733544641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/12\/31_64988\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.64988","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]},"article-number":"64988"}}